Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.30 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.30 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.30 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL21980954 | 0.98 | MEN1 (0.35) | MEN1TP53CYP1A2CYP2D6MAPT | |
| Hydrochloric Acid SCHEMBL21980955 | 0.98 | MEN1 (0.35) | MEN1TP53CYP1A2CYP2D6MAPT | |
| Bromide SCHEMBL21980957 | 0.98 | MEN1 (0.35) | MEN1TP53CYP1A2CYP2D6MAPT | |
| Bromide SCHEMBL21980956 | 0.98 | MEN1 (0.35) | MEN1TP53CYP1A2CYP2D6MAPT | |
| SCHEMBL29935874 | 0.80 | KDM4E (0.51) | MEN1TP53MAPTKMT2AKDM4E | |
| Bromide SCHEMBL29935563 | 0.79 | KDM4E (0.50) | MEN1TP53MAPTKMT2AKDM4E | |
| SCHEMBL19946631 | 0.79 | MEN1 (0.54) | MEN1TP53CYP1A2CYP2D6MAPT | |
| Hydrochloric Acid SCHEMBL29538521 | 0.77 | MEN1 (0.52) | MEN1TP53CYP1A2CYP2D6MAPT | |
| SCHEMBL29935630 | 0.76 | KDM4E (0.47) | MEN1TP53MAPTKMT2AKDM4E | |
| SCHEMBL18883319 | 0.73 | MEN1 (0.62) | MEN1TP53CYP1A2CYP2D6MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11271238-B2 | Applications of low-cost, thermal and electrochemically stable organic compounds as high performance redox active materials in redox flow batteries | UTAH STATE UNIVERSITY (US) | 2022-03-08 | — | — | US | disclosed |
| US-20200168910-A1 | APPLICATIONS OF LOW-COST, THERMAL AND ELECTROCHEMICALLY STABLE ORGANIC COMPOUNDS AS HIGH PERFORMANCE REDOX ACTIVE MATERIALS IN REDOX FLOW BATTERIES | UTAH STATE UNIVERSITY (US) | 2020-05-28 | — | — | US | disclosed |
| US-20200168910-A1 | APPLICATIONS OF LOW-COST, THERMAL AND ELECTROCHEMICALLY STABLE ORGANIC COMPOUNDS AS HIGH PERFORMANCE REDOX ACTIVE MATERIALS IN REDOX FLOW BATTERIES | UTAH STATE UNIVERSITY (US) | 2020-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11271238-B2 | Applications of low-cost, thermal and electrochemically stable organic compounds as high performance redox active materials in redox flow batteries | PPOX, NOX4, PRDX2 | MEN1 4680/4885TP53 1180/4885CYP1A2 172/4885 |
| US-20200168910-A1 | APPLICATIONS OF LOW-COST, THERMAL AND ELECTROCHEMICALLY STABLE ORGANIC COMPOUNDS AS HIGH PERFORMANCE REDOX ACTIVE MATERIALS IN REDOX FLOW BATTERIES | PPOX, NOX4, PRDX2 | MEN1 4680/4885TP53 1180/4885CYP1A2 172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.